A Technical Question About Pyrilutamide
    Research/Science 7/25/2023

    At a glance
    In this question or advice post, the primary subjects mentioned are
    ๐Ÿ’ง Pyrilutamide (topical) 0.15g 1x daily 3 months
    ๐Ÿ’Š Finasteride (oral) 1mg 1x daily
    ๐Ÿ’ง Minoxidil (topical)
    ๐Ÿ’Š Dutasteride (oral) 2x weekly
    the tone is ๐Ÿ˜ neutral with some growth results.

    Other terms

    Pyrilutamide is believed to be more effective than RU58841 and 1 mg finasteride in treating hair loss, with no systemic hormonal effects and the potential to block more than 31% of scalp DHT. It may also antagonize scalp testosterone due to its action as an androgen receptor antagonist.
    View this post in the Community โ†’

    Similar Community Posts Join

    5 / 1000+ results

      community Clascoterone - what we have right now

      in Research/Science  17 upvotes 2 weeks ago
      Clascoterone is a topical treatment for androgenetic alopecia, showing modest to moderate hair regrowth, and may be available by 2027-2028. It is considered safer than finasteride, with discussions on its effectiveness compared to RU58841 and pyrilutamide.

      community Does CosmeRNA target the root cause of MPB?

      in Chat 2 years ago
      . CumsOnYourFeet69 has been discussing a new treatment called CosmeRNA which claims to target the root cause of male pattern baldness, and is considering using it in conjunction with Minoxidil instead of Finasteride due to possible side effects. Replies have highlighted that the efficacy of this treatment is still unknown, but it could be used as an effective maintenance option if successful.

      community CB-03-01 supposed hair loss cure

      in Treatment  9 upvotes 4 years ago
      The conversation discusses why CB-03-01, a potential hair loss treatment, isn't widely discussed despite evidence of its effectiveness and safety. Some users mention other treatments like melatonin, procianidin b2, and RU58841, debating their effectiveness and safety.

    Related Research

    0 / 0 results
    — no results